Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.304 $0.440 Wednesday, 8th May 2024 CLNN stock ended at $0.390. This is 0.383% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 6.14% from a day low at $0.370 to a day high of $0.393.
90 days $0.304 $0.532
52 weeks $0.250 $1.09

Historical Clene Inc. prices

Date Open High Low Close Volume
Jan 27, 2021 $6.60 $6.76 $6.40 $6.55 113 601
Jan 26, 2021 $7.00 $7.00 $6.60 $6.76 86 868
Jan 25, 2021 $6.89 $7.00 $6.80 $7.00 58 654
Jan 22, 2021 $6.53 $6.90 $6.30 $6.89 55 607
Jan 21, 2021 $6.90 $6.90 $6.59 $6.62 86 990
Jan 20, 2021 $6.70 $7.05 $6.60 $7.04 72 337
Jan 19, 2021 $6.95 $6.95 $6.55 $6.80 82 411
Jan 15, 2021 $6.85 $7.04 $6.48 $6.65 91 672
Jan 14, 2021 $7.09 $7.46 $6.50 $6.93 80 428
Jan 13, 2021 $7.50 $7.82 $6.78 $7.10 87 260
Jan 12, 2021 $7.35 $7.82 $7.16 $7.50 32 885
Jan 11, 2021 $7.14 $7.45 $6.93 $7.35 50 012
Jan 08, 2021 $7.47 $7.47 $6.60 $6.93 55 393
Jan 07, 2021 $6.72 $7.50 $6.40 $7.07 76 286
Jan 06, 2021 $7.50 $7.60 $6.40 $6.71 95 454
Jan 05, 2021 $7.50 $7.96 $7.20 $7.35 71 964
Jan 04, 2021 $9.05 $9.25 $7.20 $7.57 143 869
Dec 31, 2020 $10.00 $10.00 $8.37 $9.01 249 770
Click to get the best stock tips daily for free!

About Clene Inc.

Clene. Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; com... CLNN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT